1-5 of 5
Thomas Kolbe
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy

Clinical Trials & Observations
Edit Porpaczy, Sabrina Tripolt, Andrea Hoelbl-Kovacic, Bettina Gisslinger, Zsuzsanna Bago-Horvath, Emilio Casanova-Hevia, Emmanuelle Clappier, Thomas Decker, Sabine Fajmann, Daniela A. Fux, Georg Greiner, Sinan Gueltekin, Gerwin Heller, Harald Herkner, Gregor Hoermann, Jean-Jacques Kiladjian, Thomas Kolbe, Christoph Kornauth, Maria-Theresa Krauth, Robert Kralovics, Leonhard Muellauer, Mathias Mueller, Michaela Prchal-Murphy, Eva Maria Putz, Emmanuel Raffoux, Ana-Iris Schiefer, Klaus Schmetterer, Christine Schneckenleithner, Ingrid Simonitsch-Klupp, Cathrin Skrabs, Wolfgang R. Sperr, Philipp Bernhard Staber, Birgit Strobl, Peter Valent, Ulrich Jaeger, Heinz Gisslinger, Veronika Sexl
Journal: Blood
Blood (2018) 132 (7): 694–706.
https://doi.org/10.1182/blood-2017-10-810739
Published: 2018
Includes: Supplemental data
Journal Articles

JAK2-Inhibitor Therapy Associated Lymphomas in Myelofibrosis: Distinct Clinico-Pathological Features Recapitulated in a Mouse Model

Sabrina Tripolt, PhD, Edit Anna Porpaczy, MD, Andrea Hoelbl-Kovacic, PhD, Bettina Gisslinger, Zsuzanna Bago-Horvath, PhD, Emilio Casanova, PhD, Thomas Decker, PhD, Daniela Fux, PhD, Gerwin Heller, MD, Harald Herkner, MD, Thomas Kolbe, PhD, Christoph Kornauth, MD, Mathias Mueller, PhD, Michaela Prchal-Murphy, PhD, Ana Iris Schiefer, MD, Christine Schneckenleithner, PhD, Cathrin Skrabs, MD, Wolfgang R. Sperr, MD, Philipp Bernhard Staber, MD PhD, Birgit Strobl, PhD, Peter Valent, MD, Ingrid Simonitsch-Klupp, MD, Gregor Hoermann, MD, Jean-Jacques Kiladjian, MD PhD, Robert Kralovics, PhD, Maria-Theresa Krauth, MD, Ulrich Jaeger, MD, Veronika Sexl, MD PhD, Heinz Gisslinger
Journal: Blood
Blood (2017) 130 (Supplement 1): 1643.
https://doi.org/10.1182/blood.V130.Suppl_1.1643.1643
Published: 2017
Journal Articles

A novel Ncr1 -Cre mouse reveals the essential role of STAT5 for NK-cell survival and development

Eva Eckelhart, Wolfgang Warsch, Eva Zebedin, Olivia Simma, Dagmar Stoiber, Thomas Kolbe, Thomas Rülicke, Mathias Mueller, Emilio Casanova, Veronika Sexl
Journal: Blood
Blood (2011) 117 (5): 1565–1573.
https://doi.org/10.1182/blood-2010-06-291633
Published: 2011
Includes: Supplemental data
Journal Articles

Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2

Florian Grebien, Marc A. Kerenyi, Boris Kovacic, Thomas Kolbe, Verena Becker, Helmut Dolznig, Klaus Pfeffer, Ursula Klingmüller, Mathias Müller, Hartmut Beug, Ernst W. Müllner, Richard Moriggl
Journal: Blood
Blood (2008) 111 (9): 4511–4522.
https://doi.org/10.1182/blood-2007-07-102848
Published: 2008
Includes: Supplemental data
Journal Articles

Interferons limit inflammatory responses by induction of tristetraprolin

Ines Sauer, Barbara Schaljo, Claus Vogl, Irene Gattermeier, Thomas Kolbe, Mathias Müller, Perry J. Blackshear, Pavel Kovarik
Journal: Blood
Blood (2006) 107 (12): 4790–4797.
https://doi.org/10.1182/blood-2005-07-3058
Published: 2006